Home › Linfoma diffuso a grandi cellule B › North Carolina › Durham
Studi clinici su Linfoma diffuso a grandi cellule B a Durham, NC
14 studi su Linfoma diffuso a grandi cellule B cercano partecipanti presso sedi a Durham e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
In reclutamentoFase 2
- Duke Blood Cancer Center, Durham
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
In reclutamentoFase 3
- Duke University Medical Center, Durham
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
In reclutamentoFase 2
- University of North Carolina Medical Center ( Site 0136), Chapel Hill · a 10 mi di distanza
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
In reclutamentoFase 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · a 10 mi di distanza
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
In reclutamentoStudio osservazionale
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
In reclutamentoFase 3
- Duke Cancer Institute, Durham
DALY II USA/ MB-CART2019.1 for DLBCL
In reclutamentoFase 2
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
In reclutamentoFase 1
- Duke University Medical Center, Durham
Registry of Older Patients With Cancer
In reclutamentoStudio osservazionale
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · a 10 mi di distanza
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
In reclutamentoFase 1
- Duke Univerisity, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
In reclutamentoStudio osservazionale
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · a 10 mi di distanza
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
In reclutamentoFase 1
- University of North Carolina, Chapel Hill · a 10 mi di distanza
A Study of NX-1607 in Adults With Advanced Malignancies
In reclutamentoFase 1
- University of North Carolina, Chapel Hill · a 10 mi di distanza
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
In reclutamentoFase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi di distanza
Studi su Linfoma diffuso a grandi cellule B in altre città
- New York City, NY21 studi
- Baldwin Park, CA19 studi
- Chicago, IL18 studi
- Houston, TX17 studi
- Los Angeles, CA17 studi
- Boston, MA16 studi
- Milwaukee, WI16 studi
- Nashville, TN15 studi
- Portland, OR15 studi
- Philadelphia, PA15 studi
- Dallas, TX13 studi
- Seattle, WA12 studi
Altri studi a Durham
- Cancro al seno63 studi
- Cancro (tutti i tipi)58 studi
- Cancro del polmone non a piccole cellule39 studi
- Mieloma multiplo37 studi
- Cancro metastatico33 studi
- Leucemia mieloide acuta33 studi
- Cancro ai polmoni32 studi
- Cancro alla prostata32 studi
- Cancro colorettale28 studi
- Leucemia linfatica cronica27 studi
- Cancro ovarico27 studi
- Insufficienza cardiaca26 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.